AgomAb Therapeutics (NASDAQ:AGMB – Get Free Report) issued its quarterly earnings results on Thursday. AgomAb Therapeutics Stock PerformanceAGMB traded down $0.82 during trading on Thursday, hitting $13.50. AgomAb Therapeutics has a twelve month low of $8.75 and a twelve month high of $17.82. B. Riley Financial initiated coverage on AgomAb Therapeutics in a research note on Thursday, July 23rd. Further ReadingReceive News & Ratings for AgomAb Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AgomAb Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.